Pharmaceutical Executive is proud to announce that it has been awarded a 2022 APEX Award of Excellence for its Pharmaceutical Executive Podcast.
The Pharm Exec podcast, which debuted in 2018, features interesting and engaging c-suite-level leaders in the pharma, biopharma, and biotech space who can share unique, helpful, and non-promotional business insights with the intention of helping educate, inspire, and enlighten their fellow leaders. Currently up to 112 biweekly episodes and counting, the podcast is co-hosted by Editor-in-Chief, Elaine Quilici, and Group Social Media Editor, Miranda Schmalfuhs. Pharm Exec would also like to recognize the podcast’s original co-hosts, Christen Harm and Michelle Maskaly.
For more information on the Pharm Exec podcast and how to get involved, read the FAQs in the following link.
PE Podcast FAQsThe APEX Awards are based on excellence in graphic design, editorial content, and the ability to achieve overall communications excellence. APEX Grand Awards honor the outstanding works in each main category, while APEX Awards of Excellence recognize exceptional entries in each of the individual subcategories. After more than 1,200 entries, 100 Grand Awards were presented to work in 14 major categories, and 485 Awards of Excellence in 100 subcategories.
The panel of judges for APEX 2022 included Ken Turtoro, APEX Senior Judge and Concepts Executive Editor; John De Lellis, Concepts Editor & Publisher; Christine Turner, Contributing Editor of the Writing That Works Archives; and John Tavaska, Consulting Editor.
To view the full list of APEX entries, click here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.